DCM
GANX icon

DME Capital Management’s Gain Therapeutics GANX Stock Holding History

DME Capital Management’s Portfolio GANX Stock Details GANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Hold
566,130
– – 0.03% 43
2025
Q4 		$1.82M Hold
566,130
– – 0.06% 37
2025
Q3 		$1M Hold
566,130
– – 0.04% 34
2025
Q2 		$1.02M Hold
566,130
– – 0.04% 31
2025
Q1 		$1.08M Hold
566,130
– – 0.05% 30
2024
Q4 		$1.22M Hold
566,130
– – 0.06% 33
2024
Q3 		$1.01M Hold
566,130
– – 0.04% 34
2024
Q2 		$725K Hold
566,130
– – 0.04% 36
2024
Q1 		$2.13M Buy
+566,130
New +$2.35M 0.1% 34

Other funds holding GANX

Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
PCM
Potomac Capital Management New York $114M AUM
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return